13D Filings
BeiGene, Ltd.
ONC
Amendment
Ownership

4.90%

Total Shares

68,551,141

Issuer CIK

1651308

CUSIP

07725L102

Event Date

May 8, 2025

Accepted

May 13, 2025, 04:15 PM

Reporting Persons (2)
Joint Filing

This is a joint filing. The reported shares may overlap between reporting persons and should not be summed.

NameType% of ClassAggregateSole VotingShared Voting
HHLR Advisors, Ltd.
Investment Adviser
4.90%68,551,141068,551,141
Hillhouse Investment Management, Ltd.
Investment Adviser
4.90%68,551,141068,551,141
Disclosure Items (2)

Security Title

Ordinary shares, par value $0.0001 per share

Issuer Name

BeiGene, Ltd.

Issuer Address

C/O MOURANT GOVERNANCE SERVICES (CAYMAN), GRAND CAYMAN, E9, KY1-1108

Percentage of Class

See rows (11) and (13) of the cover pages to this Schedule 13D for the aggregate number of Ordinary Shares and percentages of the Ordinary Shares beneficially owned by each Reporting Person. The percentage used in this Schedule 13D is calculated based upon 1,403,311,086 Ordinary Shares outstanding as of May 2, 2025, as reported in the Issuer's Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2025, filed with the Securities and Exchange Commission on May 7, 2025.

Number of Shares

See rows (7) through (10) of the cover pages to this Schedule 13D for the number of Ordinary Shares as to which each Reporting Person has the sole or shared power to vote or direct the vote and sole or shared power to dispose or to direct the disposition.

Transactions

On May 9, 2025, HHLR Fund sold 16,000,000 Ordinary Shares pursuant to a block trade with Goldman Sachs (Asia) Securities Limited at a price of HKD130 per Ordinary Share.

Date of 5% Ownership

May 9, 2025.

BeiGene, Ltd. — Schedule 13D | 13D Filings